危重症成人凝血酶生成与静脉血栓栓塞及药物预防的系统综述
本系统综述纳入15项前瞻性研究共2250例危重症成人,评估凝血酶生成试验(TGA)与静脉血栓栓塞(VTE)及药物预防药效的关联。TGA最一致地反映低分子肝素药效,抗Xa活性与抑制的内源性凝血酶潜能和凝血酶峰值相关;TGA不能可靠预测VTE,但创伤队列中较短达峰时间和滞后时间先于血栓形成。
要点
- 抗Xa活性与内源性凝血酶潜能和凝血酶峰值降低相关,支持TGA作为低分子肝素药效学指标。
- TGA不能可靠预测危重症成人VTE,创伤队列中较短达峰时间和滞后时间先于血栓形成。
- 建议在前瞻性ICU研究中标准化TGA、统一采血与给药时间并同步检测抗Xa和凝血酶生成。
核心结论
- TGA最一致地作为低分子肝素药效学指标,抗Xa活性与抑制的内源性凝血酶潜能和凝血酶峰值相关。
- TGA不能可靠预测VTE,但创伤队列中较短达峰时间和滞后时间先于血栓形成。
研究设计与样本
- 纳入15项前瞻性研究共2250例成人(≥18岁)危重症或ICU患者,其中9个外科创伤队列、4个内科ICU队列和2个混合ICU队列。
主要发现
- 校准自动凝血酶生成图是最常用的TGA平台(80.0%)。
- 8项研究(53.3%)评估TGA药效学,其中7项检测抗Xa活性,抗Xa活性与较低的内源性凝血酶潜能和凝血酶峰值相关。
临床怎么用
- TGA可用于监测低分子肝素药效,抗Xa活性与内源性凝血酶潜能和凝血酶峰值降低相关。
- 不推荐单独用TGA预测危重症成人VTE;创伤患者达峰时间或滞后时间缩短可能提示血栓风险。
- 未来ICU研究应标准化TGA检测、统一采血与给药时间,并同步检测抗Xa和凝血酶生成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) remains an important complication in critically ill adults despite standard pharmacologic thromboprophylaxis. Thrombin generation assays (TGAs) offer a global functional assessment of coagulation by capturing the kinetics and magnitude of thrombin formation and may complement conventional measures of coagulation such as anti-Xa activity. OBJECTIVE: To evaluate the association of thrombin generation with VTE and its use as a pharmacodynamic measure of thromboprophylaxis in critically ill adults. METHODS: The review was conducted according to JBI methodology and reported per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched MEDLINE, Embase, and the Central Register of Controlled Trials from inception to December 18, 2025. We included studies of adults (≥18 years) managed in high-acuity or intensive care settings with TGA measurements reported in relation to VTE incidence or thromboprophylaxis effect. RESULTS: We included 15 eligible prospective studies comprising 2250 patients (9 surgical trauma cohorts, 4 medical intensive care unit [ICU] cohorts, and 2 mixed ICU cohorts). Calibrated automated thrombography was the most used TGA platform (80.0%). Eleven studies (73.3%) evaluated associations between TGA and VTE incidence, with inconsistent findings. Some trauma cohorts identified shorter time-to-peak thrombin or lag time as predictors of VTE, while other studies found no significant associations. Of 8 studies (53.3%) assessing TGA pharmacodynamics, 7 measured anti-Xa activity, which correlated with lower endogenous thrombin potential and peak thrombin. CONCLUSIONS: TGA most consistently served as a pharmacodynamic measure of low-molecular-weight heparin effect: anti-Xa activity correlated with suppressed endogenous thrombin potential and peak thrombin. TGA did not reliably predict VTE, though shorter time-to-peak and lag time preceded thrombosis in trauma cohorts. TGA should be advanced as a coagulation-phenotyping tool in prospective ICU studies with standardized assays, consistent sampling in relation to dose timing, and concurrent anti-Xa and thrombin generation measurement.
引用
- Zhang C, Durr K, Carrier M, et al. Thrombin generation in critically ill adults: a systematic review of venous thromboembolism and pharmacological thromboprophylaxis. J Thromb Haemost. 2026. PMID: 42829085. doi:10.1016/j.jtha.2026.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。